Vitamin B12 and bone density in osteoporotic patients: A clinical trial
Over 1 in 3 people taking GLP-1s face barriers to access, including difficulty filling prescriptions most often due to shortages
In this study several hundred patients ranging in age from 12 to 80 years of age were divided into four treatment groups: no pills, placebo pills (patients were blinded from investigators), echinacea pills (patients were blinded from investigators), and echinacea pills given as unblinded open label medication
Active at picomolarnanomolar concentrations on collagen synthesis in fibroblast cultures
Side effects are uncommon and usually mild, such as temporary flushing or soreness at the site
Those patients who have a history of pancreatitis, gallbladder disease, or kidney problems may not be eligible for semaglutide GLP-1 injections